Brief: Simris Announces Promising In-Vitro Efficacy Of MC Variant For HER2-Positive Breast Cancer
25/03/2025 07:04
March 25 (Reuters) - Simris Group AB SIMRISb.ST: ANNOUNCES PROMISING IN-VITRO EFFICACY OF MC VARIANT FOR HER2-POSITIVE BREAST CANCER Source text: ID:nMFN6nhMJk Further company coverage: [SIMRISb.ST] (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))